162 related articles for article (PubMed ID: 22205445)
1. The role of breast MR imaging in pre-operative determination of invasive disease for ductal carcinoma in situ diagnosed by needle biopsy.
Goto M; Yuen S; Akazawa K; Nishida K; Konishi E; Kajihara M; Shinkura N; Yamada K
Eur Radiol; 2012 Jun; 22(6):1255-64. PubMed ID: 22205445
[TBL] [Abstract][Full Text] [Related]
2. Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Brennan ME; Turner RM; Ciatto S; Marinovich ML; French JR; Macaskill P; Houssami N
Radiology; 2011 Jul; 260(1):119-28. PubMed ID: 21493791
[TBL] [Abstract][Full Text] [Related]
3. The clinical significance of breast MRI in the management of ductal carcinoma in situ diagnosed on needle biopsy.
Miyashita M; Amano G; Ishida T; Tamaki K; Uchimura F; Ono T; Yajima M; Kuriya Y; Ohuchi N
Jpn J Clin Oncol; 2013 Jun; 43(6):654-63. PubMed ID: 23592884
[TBL] [Abstract][Full Text] [Related]
4. Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer.
Park AY; Gweon HM; Son EJ; Yoo M; Kim JA; Youk JH
Eur J Radiol; 2014 Apr; 83(4):654-9. PubMed ID: 24534119
[TBL] [Abstract][Full Text] [Related]
5. Is there different correlation with prognostic factors between "non-mass" and "mass" type invasive ductal breast cancers?
Jiang L; Zhou Y; Wang Z; Lu X; Chen M; Zhou C
Eur J Radiol; 2013 Sep; 82(9):1404-9. PubMed ID: 23540946
[TBL] [Abstract][Full Text] [Related]
6. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
[TBL] [Abstract][Full Text] [Related]
7. Application of magnetic resonance computer-aided diagnosis for preoperatively determining invasive disease in ultrasonography-guided core needle biopsy-proven ductal carcinoma in situ.
Ahn HS; Kim SM; Kim MS; Jang M; Yun B; Kang E; Kim EK; Park SY; Kim B
Medicine (Baltimore); 2020 Jul; 99(31):e21257. PubMed ID: 32756104
[TBL] [Abstract][Full Text] [Related]
8. Features of occult invasion in biopsy-proven DCIS at breast MRI.
Wisner DJ; Hwang ES; Chang CB; Tso HH; Joe BN; Lessing JN; Lu Y; Hylton NM
Breast J; 2013; 19(6):650-8. PubMed ID: 24165314
[TBL] [Abstract][Full Text] [Related]
9. Screening breast MR imaging in women with a history of lobular carcinoma in situ.
Sung JS; Malak SF; Bajaj P; Alis R; Dershaw DD; Morris EA
Radiology; 2011 Nov; 261(2):414-20. PubMed ID: 21900617
[TBL] [Abstract][Full Text] [Related]
10. Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
Lee CW; Wu HK; Lai HW; Wu WP; Chen ST; Chen DR; Chen CJ; Kuo SJ
Eur J Radiol; 2016 Apr; 85(4):780-9. PubMed ID: 26971424
[TBL] [Abstract][Full Text] [Related]
11. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
[TBL] [Abstract][Full Text] [Related]
12. MRI of the breast in patients with DCIS to exclude the presence of invasive disease.
Deurloo EE; Sriram JD; Teertstra HJ; Loo CE; Wesseling J; Rutgers EJ; Gilhuijs KG
Eur Radiol; 2012 Jul; 22(7):1504-11. PubMed ID: 22367470
[TBL] [Abstract][Full Text] [Related]
13. Preoperative breast MRI in management of patients with needle biopsy-proven ductal carcinoma in situ (DCIS).
van Bekkum S; Ter Braak BPM; Plaisier PW; van Rosmalen J; Menke-Pluijmers MBE; Westenend PJ
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1854-1860. PubMed ID: 32624292
[TBL] [Abstract][Full Text] [Related]
14. Characterization of pure high-grade DCIS on magnetic resonance imaging using the evolving breast MR lexicon terminology: can it be differentiated from pure invasive disease?
Groves AM; Warren RM; Godward S; Rajan PS
Magn Reson Imaging; 2005 Jul; 23(6):733-8. PubMed ID: 16198828
[TBL] [Abstract][Full Text] [Related]
15. Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization.
Wallace AM; Daniel BL; Jeffrey SS; Birdwell RL; Nowels KW; Dirbas FM; Schraedley-Desmond P; Ikeda DM
J Am Coll Surg; 2005 Apr; 200(4):527-37. PubMed ID: 15804466
[TBL] [Abstract][Full Text] [Related]
16. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
Huang YT; Cheung YC; Lo YF; Ueng SH; Kuo WL; Chen SC
Acta Radiol; 2011 Dec; 52(10):1064-8. PubMed ID: 21969708
[TBL] [Abstract][Full Text] [Related]
17. Screening-detected and symptomatic ductal carcinoma in situ: differences in the sonographic and pathologic features.
Shin HJ; Kim HH; Kim SM; Kwon GY; Gong G; Cho OK
AJR Am J Roentgenol; 2008 Feb; 190(2):516-25. PubMed ID: 18212241
[TBL] [Abstract][Full Text] [Related]
18. Ductal carcinoma in situ of the breast: Evaluation of main presentations on magnetic resonance imaging compared with findings on mammogram and histology.
Badan GM; Roveda D; Paito S; Fleury Ede F; Maragno B; Campos MS; Ferreira CA; Ferreira FA
Rev Assoc Med Bras (1992); 2016; 62(5):421-7. PubMed ID: 27656851
[TBL] [Abstract][Full Text] [Related]
19. Impact of Preoperative Breast MR Imaging and MR-guided Surgery on Diagnosis and Surgical Outcome of Women with Invasive Breast Cancer with and without DCIS Component.
Kuhl CK; Strobel K; Bieling H; Wardelmann E; Kuhn W; Maass N; Schrading S
Radiology; 2017 Sep; 284(3):645-655. PubMed ID: 28445683
[TBL] [Abstract][Full Text] [Related]
20. Detection of invasive components in cases of breast ductal carcinoma in situ on biopsy by using apparent diffusion coefficient MR parameters.
Mori N; Ota H; Mugikura S; Takasawa C; Tominaga J; Ishida T; Watanabe M; Takase K; Takahashi S
Eur Radiol; 2013 Oct; 23(10):2705-12. PubMed ID: 23732688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
